SARAH HARWOOD: Open Payments
NPI 1528704889 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 15 payments from 7 companies in 2025. Trend: 2023 $434 · 2024 $230 · 2025 $406
Food & beverage: $331Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Amgen Inc. | 3 | $64 |
| Lilly USA, LLC | 3 | $62 |
| ABBVIE INC. | 2 | $47 |
| REVANCE THERAPEUTICS, INC. | 1 | $40 |
| GENZYME CORPORATION | 1 | $20 |
Products named: TREMFYA, COSENTYX, OTEZLA, EBGLYSS, DAXXIFY, SKYRIZI, DUPIXENT, BOTOX.
Industry payments across ID — which companies pay providers there.
